Rutamarin
CAS: 13164-05-1
Rif. 3D-NAA16405
1mg | 436,00 € | ||
2mg | 621,00 € | ||
5mg | 1.044,00 € | ||
10mg | 1.739,00 € | ||
25mg | 3.913,00 € |
Informazioni sul prodotto
- (+)-Rutamarin
- (2S)-2-[1-(Acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propen-1-yl)-2,3-dihydro-7H-furo[3,2-g][1]benzopyran-7-one
- 7H-Furo[3,2-g][1]benzopyran-7-one, 2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-, acetate
- 7H-Furo[3,2-g][1]benzopyran-7-one, 6-(1,1-dimethylallyl)-2,3-dihydro-2-(1-hydroxy-1-methylethyl)-,acetate (8CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (2S)-(9CI)
- 7H-Furo[3,2-g][1]benzopyran-7-one,2-[1-(acetyloxy)-1-methylethyl]-6-(1,1-dimethyl-2-propenyl)-2,3-dihydro-, (S)-
- Chalepin acetate
- NSC 263654
- S-(+)-Chalepin acetate
- Vedi altri sinonimi
Rutamarin is a low molecular weight inhibitor with a molecular weight of 567. It binds to the ATP binding site of the mitochondrial membrane, thereby inhibiting its function. Rutamarin inhibits the production of inflammatory mediators in vitro and in vivo by inhibiting cyclooxygenase-2 (COX-2) and the COX-2-dependent synthesis of prostaglandins. Rutamarin also causes a reduction in colorectal adenocarcinoma cells, as well as metabolic profiles that are associated with carcinomas. This drug also affects fatty acid metabolism, which may be due to its inhibition of peroxisome proliferator activated receptor (PPAR).
Proprietà chimiche
Richiesta tecnica su: 3D-NAA16405 Rutamarin
Se si desidera richiedere un preventivo o effettuare un ordine, si prega invece di aggiungere i prodotti desiderati al carrello e poi richiedere un preventivo o un ordine dal carrello. È più veloce, più economico, e potrà beneficiare degli sconti disponibili e di altri vantaggi.